Novavax Bonds, 4.625% 1sep2031, USD (Conv.) (FIGI BBG01WW734N0, WKN A4EG92)

Download

Copy issue information to clipboard

Copy to clipboard

Data copied to the clipboard

PDF download

Choose all Reset all

Download Cancel

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist

You need to request access

Domestic bonds, Convertible, Trace-eligible, Senior Unsecured

Status

Outstanding

Amount

225,000,000 USD

Placement

***

Redemption (put/call option)

*** (-)

ACI

Country of risk

USA

Current coupon

***%

Price

Yield / Duration

Placement amount

225,000,000 USD
Outstanding amount

225,000,000 USD
USD equivalent

225,000,000 USD
Face value

1,000 USD
CFI

DCFNFR
FIGI

BBG01WW734N0
Ticker

NVAX 4.625 09/01/31

Try in 7-days Trial access

Free for company representative

Get full online access to the database
Use our powerful bond screener
Track bond prices from 400+ sources
Smart Portfolio Monitoring
Evaluate advanced analytical tools

Why Cbonds?

24 Years of Market Leadership
Trusted by clients across 90 countries for decades of reliable service
Used by Financial Professionals & Fintech central banks, asset managers, fintech innovators
Convenient platform for private investors for informed investment decisions

New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

00:23 Coverage
00:40 Bond screener
00:54 Parameters
01:10 Watchlist, Mobile app
01:15 Excel Add-in

Get access Watch full tour

Trading chart

Stock exchange selection

More about Cbonds Estimation

No more than two exchanges can be selected for comparison at the same time

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found:

Show all fields

from

ADD-IN
Cbonds add-in API
bond data api

Authorization required

You need to request access

* Data is not available within the selected subscription

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Issue information

Profile

Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is a ...

Show more Hide

Research report by Cbonds-PRAAMS

Save

Authorization required

Report download is available only paid Premium subscription access

Issuer

Go to the issuer page
Novavax
Full borrower / issuer name

Novavax
Sector

Corporate
Industry

Pharmaceutical Preparation and Biotechnology
Stocks

Novavax, ordinary share

Volume

Placement amount

225,000,000 USD
Outstanding amount

225,000,000 USD
Outstanding face value amount

225,000,000 USD

Face value

Minimum Settlement Amount

1,000 USD
Face value

1,000 USD
Outstanding face value

*** USD
Increment

*** USD

Get access to the largest bond database

Try in 7-days Demo access

Free for company representative

Evaluate advanced analytical tools
Get full online access to the database
Try our powerful bond screener
Track bond prices from 400+ sources

Get access to the largest bond database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Cash flow parameters

Reference rate

***

Coupon Rate

***

Day count convention

***

Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Maturity date

***

Cash flow

Export to Excel

Early redemption terms

***

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

Bond Search
Watchlist
Excel ADD-IN

Get access

— Are you looking for the complete & verified bond data?

— We have everything you need:

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds

Get full access to the platform from any device & via Cbonds app

Enhance your portfolio management with Cbonds Excel Add-in

Build yield maps, make chart comparison within a click

Don't wait any longer — start using Cbonds today! Register

Placement

Placement method

Closed subscription
Placement type

Public
Placement

***
Initial issue price (yield)
Geographic breakdown

***
Investor breakdown

***

Participants

Bookrunner

***
Depository

***

Conversion and exchange

Initial premium

***%
Convertible until

***
Conversion terms

***
Exchanged from

Novavax, 5% 15dec2027, USD (Conv.)

Latest issues

Show all

Similar issues

News

15/01/2026	Novavax: Entry Into Material Definitive Agreements
17/10/2025	Novavax: Entry Into A Material Definitive Agreement, Material Impairments, Other Events, Financial Statements And Exhibits
27/08/2025	Novavax: Regulation Fd Information, Other Events, Financial Statements And Exhibits
27/08/2025	Novavax: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Financial Statements And Exhibits
20/08/2025	Novavax: Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Other Events, Financial Statements And Exhibits

All organization news

IFRS/US GAAP reports

2026
	I q eng



2025
	I q eng
	II q eng
	III q eng

2024
	I q eng
	II q eng
	III q eng
	IV q eng
2023
	I q eng
	II q eng
	III q eng
	IV q eng
2022
	I q eng
	II q eng
	III q eng
	IV q eng
2021
	I q eng
	II q eng
	III q eng
	IV q eng
2020
	I q eng
	II q eng
	III q eng
	IV q eng
2019
	I q eng
	II q eng
	III q eng
	IV q eng
2018
	I q eng
	II q eng
	III q eng
	IV q eng
2017
	I q eng
	II q eng
	III q eng
	IV q eng
2016
	I q eng
	II q eng
	III q eng
	IV q eng
2015
	I q eng
	II q eng
	III q eng
	IV q eng
2014



	IV q eng

Show all Hide

Authorization required

You need to request access

Identifiers

ISIN

***
Cbonds ID

1922665
CUSIP

***
CUSIP 144A

***
CFI

DCFNFR
FIGI

BBG01WW734N0
WKN

A4EG92
Ticker

NVAX 4.625 09/01/31
Type of security by CBR

***

Bond classification

Senior Unsecured
Registered
Coupon bonds
Convertible
Trace-eligible
Amortization
Callable
CDO
Dual currency bonds
Variable rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Guaranteed
Inflation-linked principal
Supranational bond issues
Inflation-linked coupon
Mortgage bonds
Non-complex financial instruments (MiFID)
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Commercial Bonds
Subordinated
Sukuk

Show more Hide

Restructuring

***